Pregnancy in Patients With Pre-Existing Cardiomyopathies

Journal of the American College of Cardiology

Volumn 58, Issue 4, 2011, Pages 337-350

  Stergiopoulos, Kathleen ^a   Shiang, Elaine ^a   Bench, Travis ^a  

^a STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

cardiomyopathy; dilated cardiomyopathy; hypertrophic cardiomyopathy; pregnancy

Indexed keywords

ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; CONTRACEPTIVE AGENT; DIGOXIN; DIURETIC AGENT; LOOP DIURETIC AGENT; VASODILATOR AGENT; WARFARIN;

CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL EVALUATION; CONGESTIVE CARDIOMYOPATHY; CONTRACEPTION; COUNSELING; DRUG CONTRAINDICATION; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE EJECTION FRACTION; HEMODYNAMIC STRESS; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; LABOR; LUNG CONGESTION; OBSTETRIC DELIVERY; PERIPHERAL EDEMA; PREGNANCY; PREPREGNANCY CARE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SCREENING TEST; SODIUM RESTRICTION; TRANSTHORACIC ECHOCARDIOGRAPHY; FEMALE; PATHOPHYSIOLOGY; PREGNANCY COMPLICATION; RISK FACTOR;

CARDIOMYOPATHY, DILATED; CARDIOMYOPATHY, HYPERTROPHIC; COUNSELING; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; RISK ASSESSMENT; RISK FACTORS;

EID: 80053333448     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.04.014     Document Type: Review

References (70)

1. Silversides, C.K., Coleman, J.M., Physiologic changes in pregnancy. Oakley, C., Warnes, C.A., (eds.) Heart Disease in Pregnancy, 2007, Blackwell Publishing, Malden, MA, 173–185.
2. 7th Report of the Confidential Enquiries into Maternal Deaths in the UK. 2007, Royal College of Obstetrics and Gynecology, London.
3. Roos-Hesselink, J.W., Duvekot, J.J., Thorne, S.A., Pregnancy in high risk cardiac conditions. Heart 95 (2009), 680–686.
4. Grewal, J., Siu, S.C., Ross, H., et al. Pregnancy outcomes in women with dilated cardiomyopathy. J Am Coll Cardiol 55 (2009), 45–52.
5. Avila, W.S., Rossi, E.G., Ramires, J.A., et al. Pregnancy in patients with heart disease: experience with 1,000 cases. Clin Cardiol 26 (2003), 135–142.
6. Sliwa, K., Fett, J., Elkayam, U., Peripartum cardiomyopathy. Lancet 368 (2006), 687–693.
7. Gleicher, N., Elkayam, U., Peripartum cardiomyopathy, an autoimmune manifestation of allograft rejection?. Autoimmun Rev 8 (2009), 384–387.
8. Elkayam, U., Pregnancy and cardiovascular disease. Zipes, D.P., Libby, P., Bonow, R.O., Braunwald, E., (eds.) Braunwald's Heart Disease, 7th edition, 2005, Elsevier, Philadelphia, PA 1965.
9. Hilfiker-Kleiner, D., Sliwa, K., Drexler, H., Peripartum cardiomyopathy: recent insights in its pathophysiology. Trends Cardiovasc Med 18 (2008), 173–179.
10. Sliwa, K., Hilfiker-Kleiner, D., Petrie, M.C., et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail 12 (2010), 767–778.
11. van Oppen, A.C., van der Tweel, I., Alsbach, G.P., Heethaar, R.M., Bruinse, H.W., A longitudinal study of maternal hemodynamics during normal pregnancy. Obstet Gynecol 88 (1996), 40–46.
12. Yoshimura, T., Yoshimura, M., Yasue, H., et al. Plasma concentration of atrial natriuretic peptide and brain natriuretic peptide during normal human pregnancy and the postpartum period. J Endocrinol 140 (1994), 393–397.
13. Robson, S.C., Dunlop, W., Boys, R.J., Hunter, S., Cardiac output during labour. Br Med J (Clin Res Ed) 295 (1987), 1169–1172.
14. Shime, J., Mocarski, E.J., Hastings, D., Webb, G.D., McLaughlin, P.R., Congenital heart disease in pregnancy: short- and long-term implications. Am J Obstet Gynecol 156 (1987), 313–322.
15. Lui, G.K., Silversides, C.K., Khairy, P., et al. Heart rate response during exercise and pregnancy outcome in women with congenital heart disease. Circulation 123 (2011), 242–248.
16. Siu, S.C., Colman, J.M., Sorensen, S., et al. Adverse neonatal and cardiac outcomes are more common in pregnant women with cardiac disease. Circulation 105 (2002), 2179–2184.
17. Siu, S.C., Sermer, M., Colman, J.M., et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 104 (2001), 515–521.
18. Siu, S.C., Sermer, M., Harrison, D.A., et al. Risk and predictors for pregnancy-related complications in women with heart disease. Circulation 96 (1997), 2789–2794.
19. Howlett, J.G., McKelvie, R.S., Costigan, J., et al. The 2010 Canadian Cardiovascular Society guidelines for the diagnosis and management of heart failure update: heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programs. Can J Cardiol 26 (2010), 185–202.
20. Vasu, S., Stergiopoulos, K., Valvular heart disease in pregnancy. Hellenic J Cardiol 50 (2009), 498–510.
21. Kovacs, A.H., Harrison, J.L., Colman, J.M., Sermer, M., Siu, S.C., Silversides, C.K., Pregnancy and contraception in congenital heart disease: what women are not told. J Am Coll Cardiol 52 (2008), 577–578.
22. Warnes, C.A., Williams, R.G., Bashore, T.M., et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). J Am Coll Cardiol 52 (2008), e1–e121.
23. Silversides, C.K., Sermer, M., Siu, S.C., Choosing the best contraceptive method for the adult with congenital heart disease. Curr Cardiol Rep 11 (2009), 298–305.
24. Canobbio, M.M., Perloff, J.K., Rapkin, A.J., Gynecological health of females with congenital heart disease. Int J Cardiol 98 (2005), 379–387.
25. ACOG Committee on Practice Bulletins-Gynecology. ACOG practice bulletin. No.73: use of hormonal contraception in women with coexisting medical conditions. Obstet Gynecol 107 (2006), 1453–1472.
26. Gaffield, M.E., Curtis, K.M., Mohllajee, A.P., Peterson, H.B., Medical eligibility criteria for new contraceptive methods: combined hormonal patch, combined hormonal vaginal ring and the etonogestrel implant. Contraception 73 (2006), 134–144.
27. World Health Organization. Medical Eligibility Criteria for Contraceptive Use. 2004, World Health Organization, Geneva.
28. Leonard, H., O'Sullivan, J.J., Hunter, S., Family planning requirements in the adult congenital heart disease clinic. Heart 76 (1996), 60–62.
29. Reid, G.J., Siu, S.C., McCrindle, B.W., Irvine, M.J., Webb, G.D., Sexual behavior and reproductive concerns among adolescents and young adults with congenital heart disease. Int J Cardiol 125 (2008), 332–338.
30. Hameed, A.B., Chan, K., Ghamsary, M., Elkayam, U., Longitudinal changes in the B-type natriuretic peptide levels in normal pregnancy and postpartum. Clin Cardiol 32 (2009), E60–E62.
31. Resnik, J.L., Hong, C., Resnik, R., et al. Evaluation of B-type natriuretic peptide (BNP) levels in normal and preeclamptic women. Am J Obstet Gynecol 193 (2005), 450–454.
32. Folk, J.J., Lipari, C.W., Nosovitch, J.T., Silverman, R.K., Carlson, R.J., Navone, A.J., Evaluating ventricular function with B-type natriuretic peptide in obstetric patients. J Reprod Med 50 (2005), 147–154.
33. Borghi, C., Esposti, D.D., Immordino, V., et al. Relationship of systemic hemodynamics, left ventricular structure and function, and plasma natriuretic peptide concentrations during pregnancy complicated by preeclampsia. Am J Obstet Gynecol 183 (2000), 140–147.
34. Rafik Hamad, R., Larsson, A., Pernow, J., Bremme, K., Eriksson, M.J., Assessment of left ventricular structure and function in preeclampsia by echocardiography and cardiovascular biomarkers. J Hypertens 27 (2009), 2257–2264.
35. Tanous, D., Siu, S.C., Mason, J., et al. B-type natriuretic peptide in pregnant women with heart disease. J Am Coll Cardiol 56 (2010), 1247–1253.
36. Hunt, S.A., ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 46 (2005), e1–e82.
37. Schubiger, G., Flury, G., Nussberger, J., Enalapril for pregnancy-induced hypertension: acute renal failure in a neonate. Ann Intern Med 108 (1988), 215–216.
38. Cooper, W.O., Hernandez-Diaz, S., Arbogast, P.G., et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 354 (2006), 2443–2451.
39. Widerhorn, J., Rubin, J.N., Frishman, W.H., Elkayam, U., Cardiovascular drugs in pregnancy. Cardiol Clin 5 (1987), 651–674.
40. Richardson, P., McKenna, W., Bristow, M., et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 93 (1996), 841–842.
41. Manolio, T.A., Baughman, K.L., Rodeheffer, R., et al. Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop. Am J Cardiol 69 (1992), 1458–1466.
42. Felker, G.M., Thompson, R.E., Hare, J.M., et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 342 (2000), 1077–1084.
43. Pasotti, M., Klersy, C., Pilotto, A., et al. Long-term outcome and risk stratification in dilated cardiolaminopathies. J Am Coll Cardiol 52 (2008), 1250–1260.
44. Bernstein, P.S., Magriples, U., Cardiomyopathy in pregnancy: a retrospective study. Am J Perinatol 18 (2001), 163–168.
45. Avila, W.S., de Carvalho, M.E., Tschaen, C.K., et al. Pregnancy and peripartum cardiomyopathy: A comparative and prospective study. Arq Bras Cardiol 79 (2002), 484–493.
46. Fett, J.D., Christie, L.G., Murphy, J.G., Brief communication: outcomes of subsequent pregnancy after peripartum cardiomyopathy: a case series from Haiti. Ann Intern Med 145 (2006), 30–34.
47. Elkayam, U., Tummala, P.P., Rao, K., et al. Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med 344 (2001), 1567–1571.
48. Epstein, A.E., DiMarco, J.P., Ellenbogen, K.A., et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices). J Am Coll Cardiol 51 (2008), e1–e62.
49. Secher, N.J., Thayssen, P., Arnsbo, P., Olsen, J., Effect of prostaglandin E2 and F2alpha on the systemic and pulmonary circulation in pregnant anesthetized women. Acta Obstet Gynecol Scand 61 (1982), 213–218.
50. Geva, T., Mauer, M.B., Striker, L., Kirshon, B., Pivarnik, J.M., Effects of physiologic load of pregnancy on left ventricular contractility and remodeling. Am Heart J 133 (1997), 53–59.
51. Pryn, A., Bryden, F., Reeve, W., Young, S., Patrick, A., McGrady, E.M., Cardiomyopathy in pregnancy and caesarean section: four case reports. Int J Obstet Anesth 16 (2007), 68–73.
52. Alegria, J., Nishimura, R.A., Hypertrophic cardiomyopathy and pregnancy. Oakley, C., Warnes, C.A., (eds.) Heart Disease in Pregnancy, 2007, Blackwell Publishing, Malden, MA, 173–185.
53. Autore, C., Conte, M.R., Piccininno, M., et al. Risk associated with pregnancy in hypertrophic cardiomyopathy. J Am Coll Cardiol 40 (2002), 1864–1869.
54. Patel, C., Shirali, G., Pereira, N., Left ventricular noncompaction mimicking peripartum cardiomyopathy. J Am Soc Echocardiogr 20 (2007), 1009.e9–1009.e12.
55. Rehfeldt, K.H., Pulido, J.N., Mauermann, W.J., Click, R.L., Left ventricular hypertrabeculation/noncompaction in a patient with peripartum cardiomyopathy. Int J Cardiol 139 (2010), e18–e20.
56. Williams, R.I., Masani, N.D., Buchalter, M.B., Fraser, A.G., Abnormal myocardial strain rate in noncompaction of the left ventricle. J Am Soc Echocardiogr 16 (2003), 293–296.
57. Bahl, A., Swamy, A., Sharma, Y., Kumar, N., Isolated noncompaction of left ventricle presenting as peripartum cardiomyopathy. Int J Cardiol 109 (2006), 422–423.
58. Spirito, P., Autore, C., Management of hypertrophic cardiomyopathy. Br Med J 332 (2006), 1251–1255.
59. Klues, H.G., Schiffers, A., Maron, B.J., Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 26 (1995), 1699–1708.
60. Marian, A.J., Hypertrophic cardiomyopathy: from genetics to treatment. Eur J Clin Invest 40 (2010), 360–369.
61. Geisterfer-Lowrance, A.A., Kass, S., Tanigawa, G., et al. A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation. Cell 62 (1990), 999–1006.
62. Maron, B.J., Niimura, H., Casey, S.A., et al. Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations. J Am Coll Cardiol 38 (2001), 315–321.
63. Niimura, H., Bachinski, L.L., Sangwatanaroj, S., et al. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med 338 (1998), 1248–1257.
64. Thaman, R., Varnava, A., Hamid, M.S., et al. Pregnancy related complications in women with hypertrophic cardiomyopathy. Heart 89 (2003), 752–756.
65. Walker, D., Kaur, N., Bell, R., Walker, F., Hyperthrophic obstructive cardiomyopathy and pregnancy: University College London Hospital experience. Minerva Anestesiol 73 (2007), 485–486.
66. Avila, W.S., Amaral, F.M., Ramires, J.A., et al. Influence of pregnancy on clinical course and fetal outcome of women with hypertrophic cardiomyopathy. Arq Bras Cardiol 88 (2007), 480–485.
67. Probst, V., Langlard, J.M., Desnos, M., Komajda, M., Bouhour, J.B., [Familial hypertrophic cardiomyopathy. French study of the duration and outcome of pregnancy]. Arch Mal Coeur Vaiss 95 (2002), 81–86.
68. Tessler, M.J., Hudson, R., Naugler-Colville, M., Biehl, D.R., Pulmonary oedema in two parturients with hypertrophic obstructive cardiomyopathy (HOCM). Can J Anaesth 37 (1990), 469–473.
69. Pitton, M.A., Petolillo, M., Munegato, E., Ciccarese, A.A., Visentin, S., Paternoster, D.M., Hypertrophic obstructive cardiomyopathy and pregnancy: anesthesiological observations and clinical series. Minerva Anestesiol 73 (2007), 313–318.
70. Lewis, N.L., Dob, D.P., Yentis, S.M., UK registry of high-risk obstetric anaesthesia: arrhythmias, cardiomyopathy, aortic stenosis, transposition of the great arteries and Marfan's syndrome. Int J Obstet Anesth 12 (2003), 28–34.